Efficacy and Safety of Intravenous Acetaminophen Over 48 Hrs for the Treatment of Post-op Pain After Gynecologic Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

331

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
Postoperative PainHysterectomy
Interventions
DRUG

IV Acetaminophen

Intravenous acetaminophen 1 g/100 mL

DRUG

IV Placebo 100 mL solution

IV Placebo 100 mL solution dosed at same frequency as IV Acetaminophen every 6 hours (q6h)

Trial Locations (27)

10021

Weill Medical College, New York

10461

Jacobi Medical Center (Albert Einstein College of Medicine), The Bronx

11208

Albany Medical College Dept. of Anesthesiology, Albany

11794

Stony Brook Anesthesiology Health Sciences Cente, Stony Brook

16602

Allegheny Pain Managment, Altoona

19107

Thomas Jefferson University Dept. of Anesthesiology, Philadelphia

32117

Century Clinical Research, INC, Holly Hill

32960

Treasure Coast Obstetrics and Gynecology, Vero Beach

33136

University of Miami School of Medicine Dept. of Anesthesiology, Miami

33414

Visions Clinical Research, Boynton Beach

34452

Nature Coast Clinical Research, Inverness

34950

G and G Research, Inc., Ft. Pierce

35249

University of Alabama (Anesthesiology), Birmingham

35660

Helen Keller Hospital, Sheffield

43210

The Ohio State University Medical Center, Columbus

48073

William Beaumont Hospital, Royal Oak

77024

Memorial Herman/Memorial City Hospital, Houston

Texas Woman's Hospital, Houston

85023

Arizona Research Center, Inc (JC Lincoln), Phoenix

Arizona Research Center, Inc. (Arrowhead), Phoenix

85032

Precision Trials, Phoenix

91007

Arcadia Methodist Hospital, Arcadia

91105

Huntington Memorial Hospital, Pasadena

91206

Glendale Adventist Medical Center, Glendale

92672

Accurate Clinical Trials, Inc., San Clemente

08103

Cooper Anesthesia, Camden

08901

St. Peters University Hospital, Anesthesiology, New Brunswick

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mallinckrodt

INDUSTRY